Rosetta Genomics Ltd. Stock
Stocks
ROSGQ
IL0011026494
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
OTC Markets
09:30:09 2026-07-06 EDT
|
5-day change | 1st Jan Change | ||
| 0.000100 USD | +9,900.00% |
|
-.--% | +9,900.00% |
| 18-05-30 | Genoptix, Inc. cancelled the acquisition of Rosetta Genomics Ltd.. | CI |
| 18-05-21 | Rosetta Genomics Ltd.(NasdaqCM:ROSG) dropped from NASDAQ Composite Index | CI |
| Market Cap | 3.29M 2.92M 2.73M 2.49M 4.69M 317M 4.75M 33.07M 12.8M 161M 12.36M 12.09M 518M | P/E 2015 |
-1.07x | P/E 2016 | -0.54x |
|---|---|---|---|---|---|
| Enterprise Value | 845K 751K 702K 640K 1.2M 81.36M 1.22M 8.49M 3.29M 41.44M 3.17M 3.1M 133M | EV / Sales 2015 |
1.07x | EV / Sales 2016 | 0.73x |
| Free-Float |
100% | Yield 2015 * |
-
| Yield 2016 | - |
| 1 day | +9,900.00% | ||
| 3 months | +9,900.00% | ||
| Current year | +9,900.00% |
| Current year | 0 |  | 0 |
| 1 year | 0 | | 0 |
| 3 years | 0 | | 0 |
| 5 years | 0 | | 0.04 |
| 10 years | 0 | | 10.44 |
| Manager | Title | Age | Since |
|---|---|---|---|
Nicole Massoll
PRN | Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
David Sidransky
BRD | Director/Board Member | 66 | 2009-12-21 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +9,900.00% | -.--% | -.--% | -.--% | 592 | |
| +4.16% | +3.04% | +49.37% | +94.17% | 74.41B | |
| -1.14% | -1.54% | +24.43% | +78.20% | 59.26B | |
| +1.03% | -0.63% | +4.28% | +34.51% | 47.14B | |
| -3.02% | -5.20% | +27.94% | +32.51% | 42.91B | |
| +0.31% | +3.02% | +348.95% | +643.82% | 44.13B | |
| -1.96% | -0.33% | +7.04% | +99.46% | 40.79B | |
| +3.32% | +3.49% | +10.10% | +51.23% | 30.77B | |
| -2.68% | +2.92% | +29.63% | +22.72% | 29.31B | |
| -4.86% | -10.66% | -26.27% | +330.06% | 23.71B | |
| Average | +989.52% | -0.47% | +47.55% | +138.67% | 39.24B | |
| Weighted average by Cap. | +0.01% | -0.32% | +58.01% | +145.76% |
| 2015 | 2016 | |
|---|---|---|
| Net sales | 8.27M 7.34M 6.87M 6.26M 11.78M 796M 11.94M 83.08M 32.16M 405M 31.04M 30.37M 1.3B | 9.23M 8.2M 7.67M 6.99M 13.16M 889M 13.34M 92.79M 35.92M 453M 34.67M 33.92M 1.45B |
| Net income | -17.34M -15.41M -14.41M -13.13M -24.72M -1.67B -25.06M -174M -67.47M -851M -65.12M -63.71M -2.73B | -16.23M -14.42M -13.48M -12.29M -23.13M -1.56B -23.45M -163M -63.14M -796M -60.95M -59.63M -2.56B |
| Net Debt | -13.54M -12.03M -11.25M -10.25M -19.3M -1.3B -19.57M -136M -52.69M -664M -50.85M -49.75M -2.13B | -2.45M -2.17M -2.03M -1.85M -3.49M -236M -3.53M -24.58M -9.51M -120M -9.18M -8.98M -385M |
Employees
86
- Stock Market
- Stocks
- ROSGQ Stock
Select your edition
All financial news and data tailored to specific country editions
